Innovation in Mammography: Tomosynthesis Pathways (IMPETO)

Cancer Prevention and Research Institute, Italy

Status: Unknown

Conditions: Breast Cancer

Treatments: Diagnostic Test: 2D mammography; Diagnostic Test: Tomosynthesis

Study type: Interventional

Funder types: Other

Identifiers

NCT03587259

F16J16000620002

Details and patient eligibility

About

The study aims at evaluating the introduction of tomosynthesis in mammography screening, analyzing the benefits, disadvantages and feasibility in current clinical practice.

It involves women aged 45-46 that will be divided, by drawing lots, into two groups: one group will do the 2D digital mammography (control group), while the other group (intervention group) will do tomosynthesis. In the intervention group the 2D two-dimensional mammography will be reconstructed starting from tomosynthesis without exposing women to other radiation.

Full description

The IMPETO trial is a population-based, multicentre, randomised trial aimed at evaluating the clinical accuracy of Digital Breast Tomosynthesis (DBT) in adjunct to synthetic mammograms (sDM) compared to standard two-dimensional digital mammography alone (2D) in a screening programme.

45-46 year-old women resident in the screening centre catchment area of Florence and South-Est Local Health Unit are invited to attend for mammography screening and asked for informed consent to be included in the study. Women are then randomly allocated either to an usual care group (2D mammography) or to the intervention group. In the intervention group, DBT combined with sDM is proposed in order to reduce radiation exposure. The next year women of both groups will be invited to attend the usual screening examination (2D mammography). The enrolment will last 12-18 months; the whole study 36 months. The estimated sample size is 6000 women, 3000 per arm. Data will be pooled with the trial "Screening for Breast Cancer With Digital Breast Tomosynthesis", ClinicalTrials.gov Identifier: NCT02698202.

Enrollment: 6,000 estimated patients

Sex: Female

Ages: 45 to 46 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 45-46 years old women resident in the screening area

Exclusion criteria

• previous breast cancer
• written refusal to participate in the screening programme
• pregnancy, breastfeeding
• presence of prostheses;
• ongoing chemotherapy;
• impossibility to submit the informed consent for linguistic problems or for inability of women to provide informed consent;
• verified presence of BRCA1 - BRCA2 (Breast Related Cancer Antigens 1 - Breast Related Cancer Antigens 2) genetic mutation or involvement in surveillance path for heredo-familial tumor;
• previous known tomosynthesis.

Trial design

Primary purpose: Screening

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

6,000 participants in 2 patient groups

2D mammography

Active Comparator group

Description:

45-46 years old women are invited to attend the usual screening examination (2D mammography). The next year they will be invited to make a 2D mammography, according to screening protocol.

Treatment:

Diagnostic Test: 2D mammography

Tomosynthesis

Experimental group

Description:

45-46 years old women are invited to attend the Digital Breast Tomosynthesis (DBT) in adjunct to synthetic mammograms (sDM). The next year they will be invited to make a 2D mammography, according to screening protocol.

Treatment:

Diagnostic Test: Tomosynthesis